Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Macugen approved in Europe for wet AMD

Feb. 6, 2006

Efficacy shown for ISTA's tobramycin / prednisolone acetate combination product

Feb. 6, 2006

CombinatoRx and Fovea to develop novel ophthalmic therapeutics

Feb. 3, 2006

Novel ophthalmic compounds described by Alcon in a recent patent

Feb. 2, 2006

Xibrom approved for treatment of pain following cataract surgery

Feb. 1, 2006

Alpha-defensin treatment for proliferative retinopathy that complicates diabetes and prematurity

Jan. 30, 2006

Pfizer updates Canadian safety information for Macugen

Jan. 26, 2006

Tosufloxacin tosilate ophthalmic solution approved in Japan

Jan. 25, 2006

Inspire discontinues development of denufosol tetrasodium for retinal diseases

Jan. 25, 2006

Recent patent discloses novel therapeutic agents for ocular disorders

Jan. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...